ENDRA Life Sciences Finalizes Definitive Merger Agreement with Noble Africa, Securing $50M Financing
Summary
ENDRA Life Sciences, a distressed company, has finalized a merger with Noble Africa, a helium company, securing $50 million in financing and a new business direction, subject to shareholder approval and a potential reverse stock split.
Key Events
-
Definitive Merger Agreement
ENDRA's subsidiary will merge with Noble Africa LLC, a helium company, with Noble Africa surviving as a wholly-owned subsidiary of ENDRA. The agreement was finalized on June 25, 2026.
-
$50 Million Private Placement
Noble Africa secured approximately $50 million in gross proceeds from a private placement at $6.57 per unit, providing substantial capital for the combined entity.
-
New Capital Structure and Control
The combined company will be renamed Noble Africa Inc. and will implement a dual-class stock structure, with Class B shares (held by ASP Isotopes Inc.) carrying 10 votes per share, concentrating voting power.
-
Nasdaq Compliance & Cash Requirement
A reverse stock split is contemplated to maintain Nasdaq listing compliance, and ENDRA must hold at least $3.8 million in cash at closing.
Analysis
ENDRA Life Sciences, a company previously facing a Nasdaq delisting notice and a going concern warning, has finalized a definitive merger agreement with Noble Africa LLC, a helium company. This transformational transaction includes a $50 million private placement into Noble Africa, providing critical capital that is approximately nine times ENDRA's current market capitalization. The combined entity will be renamed Noble Africa Inc. and will adopt a dual-class stock structure, concentrating significant voting power with ASP Isotopes Inc. This merger fundamentally alters ENDRA's business and financial outlook, offering a path to survival and a new strategic direction.
At the time of this filing, NDRA was trading at $4.46 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $5.5M. The 52-week trading range was $2.96 to $11.96. This filing was assessed with positive market sentiment and an importance score of 10 out of 10.